IMPACT of BRAIN BIOPSY on the MANAGEMENT of PATIENTS with NONNEOPLASTIC UNDIAGNOSED NEUROLOGICAL DISORDERS

Neurosurgery

Volumn 62, Issue 4, 2008, Pages 833-837

  Pulhorn, Heinke ^a   Quigley, D Gavin ^a   Bosma, Jark J D ^b   Kirollos, Ramez ^c   Du Plessis, Daniel G ^d   Jenkinson, Michael D ^a,e  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e Clinical Science Centre   (United Kingdom)

Author keywords

Brain biopsy; Diagnostic yield; Neurological disorder; Therapeutic impact

Indexed keywords

CYCLOPHOSPHAMIDE; DONEPEZIL; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOPSY TECHNIQUE; BRAIN BIOPSY; BRAIN VASCULITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAM; ENCEPHALITIS; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; STEREOTACTIC BIOPSY; VASCULITIS; BRAIN DISEASE; BRAIN TUMOR; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; BIOPSY, FINE-NEEDLE; BRAIN DISEASES; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 48949119532     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000318168.97966.17     Document Type: Article

References (12)

1. Alrawi A, Trobe JD, Blaivas M, Musch DC: Brain biopsy in primary angiitis of the central nervous system. Neurology 53:858-860, 1999.
2. Chen TC, Hinton DR, Apuzzo ML: Diagnostic biopsy for neurological disease, in Youmans JR (ed): Neurological Surgery. Philadelphia, W.B. Saunders, 1996, pp 315-347.
3. Duna GF, Calabrese LH: Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 22:662-667, 1995.
4. Hulette CM, Earl NL, Crain BJ: Evaluation of cerebral biopsies for the diagnosis of dementia. Arch Neurol 49:28-31, 1992.
5. Javedan SP, Tamargo RJ: Diagnostic yield of brain biopsy in neurodegenerative disorders. Neurosurgery 41:823-830, 1997.
6. Kaufman HH, Catalano LW Jr: Diagnostic brain biopsy: A series of 50 cases and a review. Neurosurgery 4:129-136, 1979.
7. Kim JE, Kim DG, Paek SH, Jung HW: Stereotactic biopsy for intracranial lesions: Reliability and its impact on the planning of treatment. Acta Neurochir (Wien) 145:547-545, 2003.
8. Sawyer J, Ellner J, Ransohoff DF: To biopsy or not to biopsy in suspected herpes simplex encephalitis: A quantitative analysis. Med Decis Making 8:95-101, 1988.
9. Tilgner J, Herr M, Ostertag C, Volk B: Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: Intraoperative versus final diagnosis-influence of clinical factors. Neurosurgery 56:257-265, 2005.
10. Warren JD, Schott JM, Fox NC, Thom M, Revesz T, Holton JL, Scaravilli F, Thomas DG, Plant GT, Rudge P, Rossor MN: Brain biopsy in dementia. Brain 128:2016-2025, 2005.
11. Whiting DM, Barnett GH, Estes ML, Sila CA, Rudick RA, Hassenbusch SJ, Lanzieri CF: Stereotactic biopsy of non-neoplastic lesions in adults. Cleve Clin J Med 59:48-55, 1992.
12. Whitley RJ, Cobbs CG, Alford CA Jr, Soong SJ, Hirsch MS, Connor JD, Corey L, Hanley DF, Levin M, Powell DA: Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA 262:234-239, 1989.